MENU

Public Relations

Coverage

FY2020

You can scroll horizontally.

No. Date Media Broadcasting channel
Newspaper, journal
Headline, title Page
  9/30/2020 Web Qlife Nucleic acid drug "SRN-14/GL2-800", A doctor-initiated Phase I clinical trial  for unresectable / metastatic recurrent breast cancer starts  
  9/28/2020 Web Iyakutsushinsha Exhibits at「Innovation Japan 2020 - Online University trade show」iCONM  
  9/27/2020 TV BS FUJI If we could go to a micro world?  
  9/18/2020 Newspaper The Science News Start  an investigator-initiated Phase I clinical trials (FIRST IN HUMAN) of nucleic acid drug candidate targeting PRDM14 against breast cancer patients  
  9/15/2020 Web Asahi Shimbun DIGITAL Newsletter "KAWASAKI Coastal Area News" Vol.25 published  
  9/15/2020 Web Iyaku Keizaisha Anti-PD-1 Antibody finds a buddy  
  9/11/2020 Newspaper The Chemical Daily Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients. P10
  9/8/2020 Newspaper
Web
THE NIKKAN KOGYO SHIMBUN,LTD. Utilization of “micelle” technology: Possibility for minimally invasive drugs  
  9/7/2020 Web CareNet Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.
 
  9/4/2020 Web Nikkei Biotechnology & Business Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.
 
  9/3/2020 Web QLifePro Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.  
  9/2/2020 Web Oncology Tribune Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.  
  9/2/2020 Web Iyakutsushinsha Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.
 
  9/2/2020 Web Nikkei medical Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.
 
  9/2/2020 Web The Cancer Institute Hospital Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients.  
  9/2/2020 Web Neuro-Central A peek behind the paper – Sabina Quader and Rosalía Rodríguez-Rodríguez on nanomedicines for neuron targeting  
  8/21/2020 Newspaper The Science News Effective in combination with immune checkpoint inhibitor and nano-DDS P.4
  8/19/2020 Magazine
Web
Advanced Healthcare Materials mRNA Delivery: Polymeric Nanocarriers with Controlled Chain Flexibility Boost mRNA Delivery In Vivo through Enhanced Structural Fastening  
  8/19/2020 Web Nikkei beyond Health The effect of cancer immunotherapy provides a dramatic improvement with Nanomachines   
  8/14/2020 Newspaper
Web
MYTTLINE 【Countermeasure for coronavirus】Catch a right information in a newspaper! Get to know coronavirus ⑥Gene vaccine, expectations and anxiety  
  8/14/2020 Web Katei Gahou A drug with few side effects. Everyone's dream is consistently and gradually realized.  
  8/12/2020 Newspaper Koureisya jutaku Shimbun Progress in brain drug therapy. Effective for Alzheimer's disease.  
  8/11/2020 Web ONCOLOGY NEWS Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/11/2020 Web Medical Tribune Realization of chemo-immunotherapy using nano-DDS to dramatically enhances the efficacy of immune checkpoint inhibitors against glioblastoma  
  8/9/2020 Web DagoldInfo Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web PHYS ORG Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web 15 MINUTE NEWS Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web SunriseTechno Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web Bright Surf.com Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web nano werk Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web Bioengineer.org Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/7/2020 Web Oncolo Glioblastoma, Pinpoint attack, Utilization of nanocapsules  
  8/7/2020 Web Oncology Tribune Improve effect of chemoimmunotherapy on glioblastoma by Nano micelle dramatically.  
  8/7/2020 Newspaper The Chemical Daily New treatment for malignant brain tumor iCONM Cancer immunity + chemotherapy P.8
  8/6/2020 Web EurekAlert Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma  
  8/6/2020 Web Nikkei Biotechnology & Business iCONM, DDS for glioblastoma enhances the therapeutic effect of ICI P.34
  8/6/2020 Newspaper
Web
Nihon Keizai Shimbun  Glioblastoma, Pinpoint attack, Utilization of nanocapsules P.34
  7/28/2020 Web Burada Biliyorum #Developing a new strategy to selectively deliver therapies to the brain  
  7/28/2020 Web nano THE MAGAZINE FOR SMALL SCIENCE Developing a new strategy to selectively deliver therapies to the brain  
  7/27/2020 Newspaper
Web
Yakuji Nippo Functional advancement of gene therapy drugs-Development of intrahepatic coating agent  Innovation Center of NanoMedicine Group P.3
  7/27/2020 Web  PHARM TECH JAPAN ONLINE Innovation Center of NanoMedicine developed the new method which selectively deliver drugs only to brain tissues.  
  7/27/2020 Web  Iyakutsushinsha Develops a new method which selectively delivers drugs only to brain tissues.
Expect a creation of centrally acting drug iCONM
 
  7/26/2020 Web HYS ORG Developing a new strategy to selectively deliver therapies to the brain  
  7/26/2020 Web EurekAlert! Developing a new strategy to selectively deliver therapies to the brain  
  7/23/2020 TV TV Tokyo Stairs of Quest #42
"Aiming for a panacea with nano medicine" 
 
  7/20/2020 Newspaper The Chunichi Shimbun  "Deeper understanding of Corona!" Development and design at high speed P.20
  7/19/2020 Newspaper Tokyo Shimbun   "Deeper understanding of Corona!" Development and design at high speed P.12
  7/17/2020 TV Ruptly TV Japan: Researchers develop medical Smart Nanomachine that could cure next pandemic  
  7/10/2020 Web Ministry of education About the compilation of "Case Study of Unique Lab Design"  3/4
  7/8/2020 Newspaper The Chemical Daily Improve installation efficiency of gene drugs  Innovation Center of  NaoMedicine, etc. protect liver with PEG
Installation efficiency
P.12
  7/7/2020 Newspaper Nikkei Sangyo Shimbun Dementia treatment with nanomachines Efficient drug delivery to brain cells

P.12
  7/1/2020 Web School of Engineering, The University of Tokyo Development of a safe liver sinusoidal wall coating agent to significantly increase the efficacy of gene therapy drugs
Controlling the clearance of gene therapy drugs at the liver sinusoidal wall
 
  7/1/2020 Newspaper
Web
Nikkankogyo Shimubun Early establishment of new corona/vaccine development technology
iCONM and TMIMS conduct collaborative research
P.25
  6/30/2020 Newspaper
Web
Nikkankogyo Shimubun Colorectal cancer, gene transfer efficiency 10 times, iCONM and others administrate film agents / capsules. P.26
  6/29/2020 Web National Institutes for Quantum and Radiological Science and Technology Development of a safe liver sinusoidal wall coating agent to significantly increase the efficacy of gene therapy drugs
Controlling the clearance of gene therapy drugs at the liver sinusoidal wall
 
  6/29/2020 Web Nihon no kenkyū.com Development of a safe liver sinusoidal wall coating agent to significantly increase the efficacy of gene therapy drugs
Controlling the clearance of gene therapy drugs at the liver sinusoidal wall
 
  6/29/2020 Web Oncology Tribune Development of a safe liver sinusoidal wall coating agent to significantly
increase the efficacy of gene therapy drugs
 
  6/27/2020 Web BIGLOBE news Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy Kawasaki Institute of Industrial Promlotion Utokyo  
  6/27/2020 Web YAHOO! JAPAN news Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy Kawasaki Institute of Industrial Promlotion Utokyo  
  6/27/2020 Web Jiji Tsushin Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy Kawasaki Institute of Industrial Promlotion Utokyo  
  6/26/2020 Newspaper Science newspaper Fully synthetic artificial pancreas device, Tokyo Medical and Dental University, Nagoya University, etc. developed  
  6/26/2020 Web SSIENMAG Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy  
  6/26/2020 Web Nanotechnology News Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy  
  6/26/2020 Web 7thSpace Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy  
  6/26/2020 Web EurekAlert! Development of safe liver sinusoid coating agents to increase the efficacy of gene therapy  
  6/18/2020 Web Nikkei Beyond Health Closely watch mRNA drugs for the development of a novel coronavirus vaccine  
  6/17/2020 Newspaper
Web
Yakuji Nippo Compound development for control of hepatitis -replace cell growth factor The University of Tokyo/Kawasaki institute of Industrial Promotion Innovation Center of NanoMedicine research group  
  6/12/2020 Newspaper Science newspaper Develop vaccine production technology in preparation for return/reheat of Covid-19
iCONM and Tokyo Metropolitan Institute of Medical Science start collaborative research
 
  6/9/2020 Newspaper
Web
Nikkankogyo Shimubun Alzheimer's dementia, suppressed by low dose antibody drug iCONM and others succeeded P.23
  6/9/2020 Newspaper
Web
The Chemical Daily mRNA vaccine, iCONM and TMiMS,  develop for corona  
  6/8/2020 Newspaper
Web
Yakuji Nippo mRNA vaccine production technology, start collaborative research,
Kawasaki institute of Industrial Promotion  Innovation Center of NanoMedicine, Tokyo Metropolitan Institute of Medical Science
P.7
  6/6/2020 Web excite news iCONM and Tokyo Metropolitan Institute of Medical Science start research on mRNA vaccine for new coronavirus  
  6/6/2020 Web goo news iCONM and Tokyo Metropolitan Institute of Medical Science start research on mRNA vaccine for new coronavirus  
  6/6/2020 Web Mynavi news iCONM and Tokyo Metropolitan Institute of Medical Science start research on mRNA vaccine for new coronavirus  
  6/5/2020 Web Yahoo! JAPAN News Development of RNA vaccination technology for new coronavirus
by Kawasaki City Foundation etc.
 
  6/5/2020 Web Iyakutsushinsha iCONM and Tokyo Metropolitan Institute of Medical Science start collaborative research of creating technology for the development
of mRNA vaccine integrated with an adjuvant function. 

 
  6/5/2020 Web Jiji Tsushin Development of RNA vaccination technology for new coronavirus
by Kawasaki City Foundation etc.
 
  6/5/2020 Web Nikkei Biotechnology & Business iCONM and Tokyo Metropolitan Institute of Medical Science to develop
mRNA-based vaccine for new corona
 
  6/4/2020 TV TV KANAGAWA Collaborative research on inexpensive vaccine production New Corona  
  6/2/2020 Web Nikkei Beyond Health Insurance covers "Medical device x drug 'fifth cancer treatment'"  
  5/29/2020 Web Iyakutsushinsha Current status and prospects of nanomedicine and chemical surgery development by Dr. Nobuhiro Nishiyama (Professor, Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology)   
  5/27/2020 Web Nikkei Beyond Health Development of Nanomachines to deliver anti-dementia drugs to the brain
 
  5/22/2020 Newspaper The Chemical Daily Delivering therapeutic antibodies into the brain /
Control dementia with a low dose
 
  5/7/2020 Newspaper
Web
Asahi Shimbun
Asahi Shimbun DIGITAL
Discover new type coronavirus antibody Expected to apply to diagnostic agents and test agents  
  5/1/2020 Web BUSINESS INSIDER Aiming to supply "early mass-produced" domestically produced new coronavirus vaccine within the year. Asked the developer about the latest situation.  
  4/30/2020 Web NewsPicks Development of the Functional Polymers that Recognize Biosignals and the Application for Drug Delivery System  
  4/28/2020 Web Deutsche Well COVID-19: Nanomachines to be deployed to fight next viral pandemic  
  4/8/2020 Newspaper
Web
The Chemical Daily mRNA drug: Promising for novel corona virus / Ask Prof. Keiji Itaka, Tokyo Medical and dental University.   
  4/1/2020 Magazine Pharm Tech Japan  Challenge of Industry-government-academia for nucleic acid drug creation (6)
Development of new polymer-based DDS for practical use:
The effort centering on venture companies based on industry-academia collaboration
P.31-37
  4/1/2020 Web RikeLab Succeeded in making DNA into a single-stranded and encapsulate in nanomachines!
World's first technology opens up new possibilities for gene therapy. Science career pictorial book vol.18
Innovation Center of NanoMedicine Dr. Theofilus A. Tockary